Bitcoin Hits $100K Milestone Amid Optimism Over Trump Policies 
U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China 
Amazon Secures 200 MW Wind Power Deals in Sweden 
Pinterest Stock Falls as CFO Julia Brau Donnelly Resigns 
Salesforce Shares Surge as AI Demand Powers Q2 Earnings Beat 
Trump Administration Plans New Drug Pricing Deals With Biotech Firms 
Investors value green labels — but not always for the right reasons 
Street Poller Media and The Boom of the Street Interview Ad Industry 
Unitree Shares Plunge 45% After Blockbuster IPO, Raising China Tech Bubble Fears 
Xiaomi Unveils Xring O3 Chip for Flagship Foldable Phone 
Meta Agrees to $18 Billion Settlement, Tightens Teen Social Media Rules 
Nvidia Eyes Perplexity Investment at $30 Billion Valuation 
Samsung Shares Tumble 8% as $79 Billion Return Plan Disappoints 
BofA Names ASML Top Semiconductor Equipment Pick on Growth, Valuation 
SoftBank Eyes $20 Billion Bond Sale to Refinance OpenAI Loan 
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim 
HP Stock Drops 9% Despite Q3 Earnings Beat and Raised 2026 Outlook 
Add as a preferred source on Google
Tempus AI Inc (NASDAQ:TEM) shares surged over 18% to $41.62 in after-hours trading following a disclosure by former House Speaker Nancy Pelosi. Pelosi revealed in a recent filing that she had purchased 50 call options on the artificial intelligence-focused precision medicine firm. The options, priced between $50,000 and $100,000, have a $20 strike price and expire on January 16, 2026.
Pelosi’s disclosure also included call options in tech giants Alphabet Inc (NASDAQ:GOOGL), NVIDIA Corporation (NASDAQ:NVDA), and Amazon.com Inc (NASDAQ:AMZN).
The rally comes despite Tempus being down about 12% since its public listing in June 2024. The stock faced pressure last week when a major shareholder sold $33.1 million worth of shares, even after Tempus reported strong 2024 earnings. However, the company flagged a slowdown in contract research organization revenues, sparking some investor caution.
Sentiment around Tempus has turned highly bullish on trading platforms like Stocktwits, with discussions about the stock spiking after Pelosi’s disclosure. The platform reported increased interest and optimism, which contributed to the stock’s strong rally.
Tempus leverages artificial intelligence technology for precision medicine applications, and its growth potential continues to attract attention from prominent investors. This latest move by Pelosi, a well-known and closely watched figure in the investment community, has added momentum to the stock, drawing increased scrutiny from retail and institutional investors alike.
As interest in AI and precision medicine grows, Tempus is positioned as a key player, gaining visibility and market attention.
